Shalby AGM on Sep 10: Shanay Shah proposed as Whole-Time Director

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights

Shalby Limited convenes its 22nd AGM on September 10, 2026, primarily to approve the appointment of Shanay Vikram Shah as Whole-Time Director for five years. The related-party transaction involves a maximum annual remuneration of ₹1.50 crore. Shareholders can vote electronically via NSDL between September 5 and September 9, 2026.

powered bylight_fuzz_icon
48517479

*this image is generated using AI for illustrative purposes only.

Shalby Limited will hold its 22nd Annual General Meeting (AGM) on Thursday, September 10, 2026, at 4:00 p.m. IST through Video Conferencing (VC) or Other Audio Visual Means (OAVM). The meeting aims to transact ordinary business, including the adoption of audited financial statements for FY26, and special business centered on the appointment of Mr. Shanay Vikram Shah as a Whole-Time Director.

AGM Schedule and E-Voting Timeline

Shareholders holding shares as on the cut-off date of September 3, 2026, are eligible to vote electronically. The company has provided the facility for remote e-voting through the National Securities Depository Limited (NSDL). Chintan I Patel & Associates have been appointed as the Scrutinizer for the process.

Parameter: Details
AGM Date & Time: Thursday, September 10, 2026 at 4:00 p.m. IST
Mode: Video Conferencing (VC) / OAVM
Cut-off Date for E-Voting: Thursday, September 3, 2026
E-Voting Commencement: Saturday, September 5, 2026 at 9:00 a.m. IST
E-Voting Conclusion: Wednesday, September 9, 2026 at 5:00 p.m. IST
E-Voting Sequence Number (EVSN): 140831

Members who wish to express views or ask questions during the AGM must register as speakers by sending an email to companysecretary@shalby.in from their registered email address by September 3, 2026. The registration must include their name, demat account number or folio number, and mobile number.

Agenda Items

The AGM will address the following ordinary and special business:

Ordinary Business

  • Adoption of the Audited Standalone Financial Statements for the financial year ended March 31, 2026, along with the reports of the Board of Directors and Auditors.
  • Adoption of the Audited Consolidated Financial Statements for the financial year ended March 31, 2026, along with the report of the Auditors.

Special Business

  • Ratification of remuneration for M/s. S A & Associates, Cost Accountants, Ahmedabad (Firm Registration No. 000347), as Cost Auditors for FY27 at ₹1,10,000 plus applicable taxes and out-of-pocket expenses.
  • Appointment of Mr. Shanay Vikram Shah (DIN: 02726541) as a Director, liable to retire by rotation.
  • Appointment of Mr. Shanay Vikram Shah (DIN: 02726541) as Whole-Time Director for a term of five consecutive years, effective from August 12, 2026.

Proposed Appointment of Whole-Time Director

The Board of Directors, based on the recommendation of the Nomination and Remuneration Committee, appointed Mr. Shanay Vikram Shah as an Additional Director (Whole-Time Director) for five years, subject to shareholder approval at the AGM.

Mr. Shanay Vikram Shah, aged 35, holds a Bachelor's degree in Science with Honours in Accounting and Finance from the University of Warwick, UK, and a Master's degree in International Health Management from Imperial College London, UK. He is also a Chartered Financial Analyst (CFA). With over 13 years of experience in the healthcare industry since joining the company in October 2013, he has expertise in international business, strategy, financial operations, human resources, and investor relations. He holds 1,37,525 equity shares, representing 0.13% of the paid-up equity share capital.

Key Terms of Appointment

Parameter: Details
Designation: Whole-Time Director
Tenure: 5 consecutive years from August 12, 2026
Remuneration: Not exceeding ₹1.50 crore per annum
Termination Notice: Six months' written notice by either party
Retirement: Liable to retire by rotation

Upon assuming the role of Whole-Time Director, Mr. Shanay Vikram Shah will cease to hold the office of President – International Business, and the associated remuneration will be discontinued effective August 12, 2026.

Related Party Disclosure

The appointment is classified as a related party transaction under Section 2(76) of the Companies Act, 2013, and Regulation 2(1)(zb) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as Mr. Shanay Vikram Shah is the son of Dr. Vikram Shah (DIN: 00011653), the Promoter and Chairman & Managing Director. Since the monthly remuneration exceeds ₹2,50,000, member approval by ordinary resolution is required under Section 188(1) of the Companies Act, 2013. The transaction is not deemed "material" under Regulation 23(1) of the SEBI Listing Regulations.

Book Closure and Other Details

The book closure period runs from Friday, September 4, 2026, to Thursday, September 10, 2026, inclusive. The Board has not recommended any dividend for FY26. The Annual Report for FY26 and the AGM Notice are available on the company's website and have been dispatched electronically to registered shareholders. For members without registered email addresses, individual letters containing the weblink to the Annual Report were sent in compliance with Regulation 36(1)(b) of the SEBI Listing Regulations.

Historical Stock Returns for Shalby

1 Day5 Days1 Month6 Months1 Year5 Years
+1.66%-7.06%-9.75%-1.54%-39.67%-27.06%

How might the transition of Mr. Shanay Vikram Shah to Whole-Time Director influence Shalby Limited's international expansion strategy and revenue growth projections?

What are the potential implications for the company's capital allocation strategy given the Board's decision not to recommend a dividend for FY26?

How will the appointment of a family member as a key executive impact corporate governance perceptions and minority shareholder confidence?

Shalby releases Q1 FY27 earnings call transcript with management commentary

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights

Shalby Limited disclosed its Q1 FY27 earnings call transcript on August 19, 2026. The filing details consolidated revenue of ₹338.6 crore and PAT of ₹10.5 crore. Management emphasized improved hospital occupancy rates and the first-time EBITDA break-even at the Gurgaon unit, signaling operational stabilization across key segments.

powered bylight_fuzz_icon
48155073

*this image is generated using AI for illustrative purposes only.

Shalby Limited has released the transcript of its earnings conference call for the first quarter of fiscal year 2027 (Q1 FY27). The call took place on August 13, 2026, and the transcript was filed with stock exchanges on August 19, 2026.

The company issued the disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The document references the company's intimation letter dated July 29, 2026, and Regulation 46(2).

Call Details

The earnings call was conducted on August 13, 2026, hosted by Elara Securities. Senior management, including Chairman and Managing Director Dr. Vikram Shah, Group CFO Amit Kumar, and Chief Operating Officer Dr. Nishita Shukla, participated in the session to discuss the unaudited financial results for Q1 FY27.

During the call, management reported that consolidated revenues stood at ₹338.6 crore, an 11.6% year-on-year increase from ₹303.4 crore in Q1 FY26. Consolidated EBITDA improved slightly to ₹49 crore from ₹48.5 crore, while consolidated PAT rose to ₹10.5 crore from ₹7.7 crore in the corresponding quarter last year.

Key operational highlights discussed included:

  • Standalone hospital revenue of ₹259 crore, up approximately 7% year-on-year.
  • Hospital occupancy rate reached 51% (excluding Shalby International), up from 54% previously, with occupied beds increasing to 701.
  • Shalby International (Gurgaon unit) achieved EBITDA break-even for the first time since acquisition.
  • MedTech business delivered a revenue of approximately ₹47 crore, reflecting strong growth momentum.

Investors can access the full transcript via the link provided in the official exchange filing. The document was signed by Tushar Shah, Vice President & Company Secretary.

What the Numbers Show

The release of the transcript provides granular insight into the drivers behind Shalby’s Q1 FY27 performance. While consolidated EBITDA margins contracted to 14.5% from 16% in Q1 FY26, the standalone hospital segment maintained robust profitability with an EBITDA margin of 18.4%. The improvement in hospital occupancy to 51% alongside stable ARPOB suggests volume-led growth is supporting top-line expansion, even as margin pressures persist due to new specialty deployments and TPA renewals. The achievement of EBITDA positivity at the Gurgaon unit marks a significant turnaround milestone for the international segment.

Historical Stock Returns for Shalby

1 Day5 Days1 Month6 Months1 Year5 Years
+1.66%-7.06%-9.75%-1.54%-39.67%-27.06%

How will the ongoing margin pressures from new specialty deployments and TPA renewals impact Shalby's EBITDA trajectory in Q2 FY27?

What specific operational strategies is Shalby employing to sustain the turnaround momentum at the Gurgaon unit beyond its initial EBITDA break-even?

Given the 11.6% revenue growth, what are the primary drivers expected to fuel the MedTech business's continued expansion in the coming quarters?

More News on Shalby

Must Read Next

Earnings

Shree Cement Q2 Results: board meeting scheduled for October 23 57 mins ago
no imag found
Steamhouse India expects steam business to maintain 23% profit margin 3 hrs ago

Stocks

Softtech Engineers secures ₹92.95 crore AI project from JNPA 7 mins ago
no imag found
Puravankara secures ₹2,600 crore redevelopment project in Goregaon West 7 mins ago
1 Year Returns:-39.67%